OBJECTIVE: To estimate the prevalence of lymph node involvement in women with primary mucinous ovarian carcinomas. METHODS: A retrospective study was performed of patients with primary mucinous ovarian carcinomas evaluated at a single institution between 1985 and 2007. A gynecologic oncology pathologist evaluated all cases. Patients with tumors of low malignant potential and mucinous carcinomas metastatic to the ovary from other primary sites were excluded. RESULTS: Patients with primary mucinous ovarian carcinomas were identified (n=107). All patients underwent primary surgery. At time of surgery, 93 patients (87%) had tumors that grossly appeared to be confined to the ovary, and 14 patients (13%) had evidence of extraovarian disease. Of the 93 patients with tumors that grossly appeared to be confined to the ovary at surgical exploration, 51 (55%) underwent lymphadenectomy (n=27 pelvic and paraaortic, n=19 pelvic only, n=5 paraaortic only). Of these 51 patients, none had metastatic disease to the pelvic or paraaortic lymph nodes. In addition, there were no significant differences in progression-free survival and overall survival rates between the patients who underwent lymphadenectomy and those who did not. CONCLUSION: There were no cases of isolated lymph node metastases among women with primary mucinous carcinoma grossly confined to the ovary, suggesting that routine lymphadenectomy may be omitted in these patients. LEVEL OF EVIDENCE: III.
OBJECTIVE: To estimate the prevalence of lymph node involvement in women with primary mucinous ovarian carcinomas. METHODS: A retrospective study was performed of patients with primary mucinous ovarian carcinomas evaluated at a single institution between 1985 and 2007. A gynecologic oncology pathologist evaluated all cases. Patients with tumors of low malignant potential and mucinous carcinomas metastatic to the ovary from other primary sites were excluded. RESULTS:Patients with primary mucinous ovarian carcinomas were identified (n=107). All patients underwent primary surgery. At time of surgery, 93 patients (87%) had tumors that grossly appeared to be confined to the ovary, and 14 patients (13%) had evidence of extraovarian disease. Of the 93 patients with tumors that grossly appeared to be confined to the ovary at surgical exploration, 51 (55%) underwent lymphadenectomy (n=27 pelvic and paraaortic, n=19 pelvic only, n=5 paraaortic only). Of these 51 patients, none had metastatic disease to the pelvic or paraaortic lymph nodes. In addition, there were no significant differences in progression-free survival and overall survival rates between the patients who underwent lymphadenectomy and those who did not. CONCLUSION: There were no cases of isolated lymph node metastases among women with primary mucinous carcinoma grossly confined to the ovary, suggesting that routine lymphadenectomy may be omitted in these patients. LEVEL OF EVIDENCE: III.
Authors: I Vergote; J De Brabanter; A Fyles; K Bertelsen; N Einhorn; P Sevelda; M E Gore; J Kaern; H Verrelst; K Sjövall; D Timmerman; J Vandewalle; M Van Gramberen; C G Tropé Journal: Lancet Date: 2001-01-20 Impact factor: 79.321
Authors: Jeffrey D Seidman; Robert A Soslow; Russell Vang; Jules J Berman; Mark H Stoler; Mark E Sherman; Esther Oliva; Andre Kajdacsy-Balla; David M Berman; Larry J Copeland Journal: Hum Pathol Date: 2004-08 Impact factor: 3.466
Authors: Philippe Morice; Franklin Joulie; Sophie Camatte; David Atallah; Roman Rouzier; Patricia Pautier; Christophe Pomel; Catherine Lhommé; Pierre Duvillard; Damienne Castaigne Journal: J Am Coll Surg Date: 2003-08 Impact factor: 6.113
Authors: William E Winter; G Larry Maxwell; Chunqiao Tian; Jay W Carlson; Robert F Ozols; Peter G Rose; Maurie Markman; Deborah K Armstrong; Franco Muggia; William P McGuire Journal: J Clin Oncol Date: 2007-08-20 Impact factor: 44.544
Authors: Viviane Hess; Roger A'Hern; Nazar Nasiri; D Michael King; Peter R Blake; Desmond P J Barton; John H Shepherd; T Ind; J Bridges; K Harrington; Stanley B Kaye; Martin E Gore Journal: J Clin Oncol Date: 2004-03-15 Impact factor: 44.544
Authors: Katherine C Kurnit; Abdulrahman K Sinno; Bryan M Fellman; Aaron Varghese; Rebecca Stone; Anil K Sood; David M Gershenson; Kathleen M Schmeler; Anais Malpica; Amanda N Fader; Michael Frumovitz Journal: Obstet Gynecol Date: 2019-12 Impact factor: 7.661
Authors: Koji Matsuo; Hiroko Machida; Tsuyoshi Takiuchi; Brendan H Grubbs; Lynda D Roman; Anil K Sood; David M Gershenson Journal: Gynecol Oncol Date: 2017-01-26 Impact factor: 5.482
Authors: Jennifer J Mueller; Henrik Lajer; Berit Jul Mosgaard; Slim Bach Hamba; Philippe Morice; Sebastien Gouy; Yaser Hussein; Robert A Soslow; Brooke A Schlappe; Qin C Zhou; Alexia Iasonos; Claus Høgdall; Alexandra Leary; Roisin E O'Cearbhaill; Nadeem R Abu-Rustum Journal: Int J Gynecol Cancer Date: 2018-06 Impact factor: 3.437
Authors: Koji Matsuo; Yongmei Huang; Oliver Zivanovic; Muneaki Shimada; Hiroko Machida; Brendan H Grubbs; Lynda D Roman; Jason D Wright Journal: Gynecol Oncol Date: 2019-07-04 Impact factor: 5.482
Authors: H Mahdi; R E Swensen; R Hanna; S Kumar; R Ali-Fehmi; A Semaan; H Tamimi; R T Morris; A R Munkarah Journal: Br J Cancer Date: 2011-07-19 Impact factor: 7.640